Mount Sinai Liver Cancer Program - 14th Anniversary Liver Cancer: Advances in Science and Clinical Management

Add to Calendar Mount Sinai Liver Cancer Program - 14th Anniversary Liver Cancer: Advances in Science and Clinical Management 12/13/2019 8:30:00 AM 12/13/2019 5:00:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/livercancer2019 Description: This conference will assemble multidisciplinary experts on chronic liver diseases, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) from the Mount Sinai Liver Cancer Program and two outstanding invited lecturers. The meeting is intended to provide a summary of the state-of the-art knowledge of the novel advancements reported in 2019 on the pathogenesis and clinical management of liver cancer, including the r... Icahn School of Medicine at Mount Sinai, Hatch Auditorium, 1468 Madison Avenue false MM/DD/YYYY


Date & Location
Friday, December 13, 2019, 8:30 AM - 5:00 PM, Icahn School of Medicine at Mount Sinai, Hatch Auditorium, 1468 Madison Avenue

Target Audience
Specialties - Academic/Research, Family Practice, Gastroenterology, General Practice, General Surgery, Hematology, Hepatology, Infectious Diseases, Internal Medicine, Liver Diseases, Multiple Specialties, Nurse Practitioner, Nursing, Oncology, Palliative Medicine, Pathology, Physician Assistant, Primary Care Physician, Psychiatry, Radiation Oncology, Radiology, Surgeon

Course Overview
This conference will assemble multidisciplinary experts on chronic liver diseases, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) from the Mount Sinai Liver Cancer Program and two outstanding invited lecturers. The meeting is intended to provide a summary of the state-of the-art knowledge of the novel advancements reported in 2019 on the pathogenesis and clinical management of liver cancer, including the research conducted in Mount Sinai.

Objectives
  1. Understand the epidemiology and risk factors of liver cancer.
  2. Provide adequate clinical indications for the treatment of patients with liver cancer according to the most recent international guidelines.
  3. Understand the mechanism of action of novel targeted therapies and immune therapies coming for the management of these diseases.
  4. Analyze the prospects of novel therapies (combination therapies and radiation therapy) in the management of liver cancer

Accreditation
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credits
AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)